Ahn B, Jang SJ, Hwang HS. Additional reporting of diffuse and homogeneous ROS-1 SP384 immunoreactivity enhances prediction of ROS1 fusion-positive non-small cell lung cancer. Am J Clin Pathol 2024 Sep 12:aqae118. doi: 10.1093.
PMID: 39267255